Get the Stockscreener App
134.44
0.89%
1.275
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories stock is traded at $134.44, with a volume of 993.62K.
It is up +0.89% in the last 24 hours and up +15.04% over the past month.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$133.17
Open:
$132.41
24h Volume:
993.62K
Relative Volume:
0.19
Market Cap:
$230.98B
Revenue:
$41.95B
Net Income/Loss:
$13.40B
P/E Ratio:
17.57
EPS:
7.65
Net Cash Flow:
$6.49B
1W Performance:
+2.87%
1M Performance:
+15.04%
6M Performance:
+20.62%
1Y Performance:
+13.99%
1-Day Range:
$132.41
$134.47
1-Week Range:
$128.25
$134.47
52-Week Range:
$99.71
$134.47
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott Laboratories
Sector
Industry
Phone
(224) 667-6100
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
134.34 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.33 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
385.51 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.67 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.98 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-24 | Initiated | Oppenheimer | Outperform |
| Sep-19-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Downgrade | Edward Jones | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-21-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-20-23 | Reiterated | Barclays | Overweight |
| Apr-20-23 | Reiterated | Bernstein | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Raymond James | Outperform |
| Apr-20-23 | Reiterated | UBS | Buy |
| Apr-20-23 | Reiterated | Wolfe Research | Underperform |
| Mar-29-23 | Initiated | UBS | Buy |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-27-22 | Reiterated | Credit Suisse | Outperform |
| Jan-27-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | UBS | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-14-21 | Initiated | Redburn | Neutral |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Jan-28-21 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Jun-01-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-02-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Feb-07-19 | Reiterated | BofA/Merrill | Buy |
| Jan-02-19 | Downgrade | Citigroup | Neutral → Sell |
| Nov-30-18 | Upgrade | Goldman | Neutral → Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Jan-30-18 | Reiterated | Citigroup | Neutral |
| Jan-25-18 | Reiterated | Stifel | Buy |
| Jan-25-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-19-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-19-17 | Reiterated | Stifel | Buy |
View All
Abbott Laboratories Stock (ABT) Latest News
Point of Care Diagnostic Market to grow at a CAGR of 7.5% (2024 – 2030): Wissen Research - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Shares Sold by Paradigm Asset Management Co. LLC - MarketBeat
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Bradley Foster & Sargent Inc. CT Grows Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cordatus Wealth Management LLC Acquires Shares of 23,574 Abbott Laboratories (NYSE:ABT) - MarketBeat
Nicholson Wealth Management Group LLC Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Principal Securities Inc. Acquires 8,389 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Meitav Investment House Ltd. Reduces Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Advyzon Investment Management LLC Acquires New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Americana Partners LLC Sells 2,006 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
D.A. Davidson & CO. Increases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Strategic Financial Concepts LLC Takes $316,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lateral Flow Assay Market Top PlayersAbbott Laboratories - openPR
Kornitzer Capital Management Inc. KS Purchases 9,314 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Ramsay Stattman Vela & Price Inc. Purchases 6,346 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Reaches New 52-Week HighHere's Why - MarketBeat
ING Groep NV Sells 99,117 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Boston Financial Mangement LLC Decreases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Parcion Private Wealth LLC Buys 2,161 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Handelsbanken Fonder AB Reduces Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ieq Capital LLC Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Corps Capital Advisors LLC Takes Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Bioelectric Medicine Market Key Players AnalysisAbbott - openPR
bLong Financial LLC Buys New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Private Advisor Group LLC Acquires 90,662 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Alberta Investment Management Corp Purchases 80,435 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Global Retirement Partners LLC Has $6.63 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
DSM Capital Partners LLC Acquires 370,049 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Atlas Legacy Advisors LLC Acquires New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Boosted by Atria Wealth Solutions Inc. - MarketBeat
Bank of Jackson Hole Trust Purchases New Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
10,812 Shares in Abbott Laboratories (NYSE:ABT) Purchased by GAM Holding AG - MarketBeat
MOKAN Wealth Management Inc. Makes New $2.36 Million Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories - Yahoo Finance
Callahan Advisors LLC Buys 10,022 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Purchased by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Buckingham Capital Management Inc. Sells 24,982 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Lifted by Venturi Wealth Management LLC - MarketBeat
Diabetic Retinopathy Market Projected To Witness Substantial Growth 2025-2032:Abbott Laboratories, Novartis - EIN News
Abbott Laboratories (NYSE:ABT) Hits New 1-Year HighWhat's Next? - MarketBeat
Medical Nutrition Market Top Players- Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc. - openPR
Sawgrass Asset Management LLC Cuts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Attessa Capital LLC Takes $295,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Rhumbline Advisers Sells 28,139 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
WealthPLAN Partners LLC Reduces Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stake Boosted by Campbell Wealth Management - MarketBeat
First Merchants Corp Lowers Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Position Trimmed by Vontobel Holding Ltd. - MarketBeat
BXM Wealth LLC Acquires Shares of 3,269 Abbott Laboratories (NYSE:ABT) - MarketBeat
Stanley Laman Group Ltd. Sells 4,927 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories Stock (ABT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):